Aves Labs Inc - Company Review
Aves Labs Inc - Company ReviewSummary
Aves Labs Inc (Aves) is a biotechnology company that offers polyclonal chicken antibodies. The company’s products include glial and schwann cell markers; secondary antibodies, epitope tag, neuronal cell markers, 6XHIS, beta-gal and GFP antibodies; immunoprecipitation reagents, and blocking reagents. It provides custom antibody production services including custom antibody production, antibody purification, custom peptide synthesis, and primary antibody labeling and ELISA analysis services. Aves offers anti-peptide antibodies against different regions of amyloid precursor proteins and b-amyloid peptides. The company also produces bulk custom tagging of antibodies with other markers. It markets products through a network of distributors in the US. Aves is headquartered in Tigard, Oregon, the US.
This comprehensive company report of Aves Labs Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.